Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Assets Average: 2011-2025

Historic Assets Average for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to $238.7 million.

  • Abeona Therapeutics' Assets Average rose 87.49% to $238.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.7 million, marking a year-over-year increase of 87.49%. This contributed to the annual value of $86.5 million for FY2024, which is 34.88% up from last year.
  • Abeona Therapeutics' Assets Average amounted to $238.7 million in Q3 2025, which was up 38.12% from $172.8 million recorded in Q2 2025.
  • Abeona Therapeutics' Assets Average's 5-year high stood at $238.7 million during Q3 2025, with a 5-year trough of $41.7 million in Q3 2022.
  • For the 3-year period, Abeona Therapeutics' Assets Average averaged around $106.2 million, with its median value being $104.1 million (2025).
  • In the last 5 years, Abeona Therapeutics' Assets Average crashed by 66.57% in 2022 and then skyrocketed by 112.81% in 2024.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Assets Average stood at $99.3 million in 2021, then tumbled by 48.15% to $51.5 million in 2022, then rose by 26.33% to $65.0 million in 2023, then soared by 76.44% to $114.8 million in 2024, then soared by 87.49% to $238.7 million in 2025.
  • Its Assets Average stands at $238.7 million for Q3 2025, versus $172.8 million for Q2 2025 and $104.1 million for Q1 2025.